Enter your email address below and subscribe to our newsletter

Patient Education

Share your love

Innovative VR Solution for Cataract Surgery Training

At the annual meeting of the American Society of Cataract and Refractive Surgery (ASCRS) in Boston, Orbis International, together with FundamentalVR, introduced a virtual reality (VR) training tool. This immersive VR solution is especially designed for use in low- and…

The Pineal Gland & The Eye of Horus I OBN

Since Galen, a Greek physician and philosopher, first recorded information on the pineal gland’s significance, it has been the focus of extensive research. Colleagues of Galen held the opinion that the pineal controlled the movement of “psychic pneuma,” an ethereal substance…

Lenz Therapeutics Reports Study Success for Presbyopia

Lenz Therapeutics announced positive topline results from its Phase 3 CLARITY study, evaluating two investigational formulations, LNZ100 and LNZ101, aimed at treating presbyopia. The study’s findings showcase the effectiveness and safety of these formulations, particularly highlighting LNZ100 (1.75% aceclidine) for…

Vance Thompson, MD, to Lead ASCRS as New President

The American Society of Cataract and Refractive Surgery (ASCRS) is poised to welcome Vance Thompson, MD, as its new president during the organization’s 2024 annual meeting, which begins this Friday at the Boston Convention and Exhibition Center in Boston. This…

Zeiss Completes Acquisition of DORC

In a significant move for the ophthalmology sector, Carl Zeiss Meditec announced the successful acquisition of 100% shares of the Dutch Ophthalmic Research Center (DORC), a transaction that has now received all necessary regulatory approvals. This acquisition from Eurazeo SE,…

Qlaris Bio Begins Phase 2 Trials of QLS-111 for Eye Conditions

Qlaris Bio has commenced two critical Phase 2 trials in the United States for its innovative intraocular pressure (IOP)-lowering product, QLS‑111. These masked, randomized clinical trials are designed to investigate the efficacy of QLS‑111 in patients suffering from ocular hypertension…

West Point and Verséa Sign Supply Deal for Ocular Products

In a significant move for ocular health and treatment, West Point Optical Group (WPOG), the operator of 86 Pearle Vision stores, has joined forces with Verséa Ophthalmics in an exclusive partnership supply agreement. Under this new deal, Verséa Ophthalmics is…

Melt Pharma Raises $24M for Sedation Tablet

Melt Pharmaceuticals has successfully completed a significant financial milestone, securing approximately $24 million through its Series B Preferred Stock financing round. This latest funding round saw contributions from both new and returning investors, setting the stage for the accelerated development…

Pantheon Vision Gets Another $1.8M for Corneal Implants

Pantheon Vision, a pioneering medical device company in the pre-clinical stage focused on developing bioengineered corneal implants, has secured an additional $1.8 million in funding. This recent financial boost is part of a second tranche from KeraLink International (KLI), following…

Study Highlights Differences in Perception Speed

In a recent study conducted by researchers at Trinity College Dublin, it has been discovered that individuals vary significantly in their ability to perceive visual signals, essentially meaning some people can see the world at a higher “frame rate” than…

Stay informed and not overwhelmed, subscribe now!